2024 Agenda

EXPERIENCE

Tier 1 Sponsor Advisory Board Opportunity (Sold Out)

EXPERIENCE

OWL Socal Chapter Meeting

EXPERIENCE

Partnership Pursuit: Physician & Entrepreneur Reception 

This is a unique opportunity for you to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest. These companies will be within the medical industry, not necessarily ophthalmic specific, and provide a good opportunity to contribute your diverse perspective.

EXPERIENCE

Welcome Reception

EXPERIENCE

Tier 1 Sponsor Advisory Board Opportunity (Sold Out)

EXPERIENCE

Registration, Exhibits & Continental Breakfast

Network with colleagues! You can also set appointments within our virtual platform or take part in a networking session catered to your interests.

OPENING

Opening Comments

Octane CEO, Bill Carpou will reflect on the impact of ophthalmology in Southern California and beyond.

Bill Carpou, CEO, Octane

State of the Ophthalmic Industry Report

Hear from an industry-leading expert on eyecare’s current and future investment trends and growth opportunities.

Sergio Rossi, Managing Director & Partner, Boston Consulting Group

KEYNOTE

Keynote Interview

Euan Thomson, PhD, President of Ophthalmic Devices and Head of Digital Business Unit, Carl Zeiss Meditec Inc.

Jim Mazzo, Executive Chairman, Neurotech, Co-Founder, Octane

PANEL

Innovations in the Posterior Segment

Leading Posterior Segment surgeons will present their favorite new and upcoming technologies. An interactive panel discussion will follow the presentations.

Bob Avery, MD, California Retina Consultants

Doug Faunce, Executive Director, External Disease, AbbVie

Aaron Osborne, Executive Director Ophthalmology, USMA, Genentech, Inc.

PANEL

Refractive Panel, Anterior Segment, Cornea

Leading Anterior Segment surgeons will present the new and future technologies they are most excited about for their practices. An interactive panel discussion will follow the presentations.

Ehsan Sadri, MD, FACS, CEO and Founder, Visionary Eye Institute (Moderator)

Alex Lopez, Chief Commercial Officer, Ace Vision

Lisa Nijm, MD, JD, Founder and Medical Director, Warrenville Eyecare and LASIK

Adam Szaronos, President & CEO, Trukera Medical

PANEL

Innovations and Applications in Genetic Engineering and Cell Transplantation

The future of medicine is here! This cutting-edge panel will feature leading experts in genetic engineering and cell transportation. The panelists will discuss which technologies are at the forefront and where the industry is headed in this exciting space.

Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine (Moderator)

Greg Kunst, Chief Executive Officer, Aurion Biotech

Jeffrey L. Goldberg, MD, PhD, Co-founder and Director, Board of Managers, Emmecell

John Pollack, MD, Chief Medical Officer, jCyte, Inc.

Richard Small, Chief Executive Officer & Board of Directors, Neurotech Pharmaceuticals, Inc.

EXPERIENCE

Break: Networking, Exhibits & Coffee

TARSUS FIRESIDE CHAT

Aziz Mottiwala, Chief Commercial Officer, Tarsus Pharmaceuticals, Inc.

John Hovanesian, MD, FACS, Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA 

PANEL

Private Equity: The Good, The Bad, The Ugly

Join our industry experts in hearing the latest information on what is happening with Private Equity. Learn about how it works, the existing challenges, and what we will see in

Cynthia Matossian, MD, FACS, President, CM Associates, LLC

Farrel “Toby” Tyson, MD, FACS, Tyson Eye

Denise M. Visco, MD, MBA, Medical Director, Eyes of York

EXPERIENCE

Ramin Valian, Vice President-Eye Care and Pipeline Commercialization Strategy, AbbVie

Nicole Fram, MD, Managing Partner, Advanced Vision Care

EXPERIENCE

The Roger Steinert, MD Legacy Award Presented by The Gavin Herbert Eye Institute

Baruch Kuppermann, MD, PhD, Steinert Endowed Professor, Chair, Department of Ophthalmology, Director, Gavin Herbert Eye Institute, University of California, Irvine

EXPERIENCE

Lunch and Networking

EXPERIENCE

Capital & Growth Company Presentations

Judges:

Mayssa Attar, PhD, Head of Pharmaceuticals R&D, Bausch & Lomb

Tara Capalbo, General Manager, Ocular Surface Disease and Glaucoma

PANEL

The Investment Landscape

Andrew Stewart, President, Global Ophthalmic Pharmaceuticals, Bausch & Lomb (moderator)

Jeffry Weinhuff, Founder & Managing Partner, Visionary Ventures

EXPERIENCE

Break: Exhibits & Networking

PANEL

The Changing Ophthalmic Practice

Industry and physician experts will discuss the latest in aesthetics, cash pay technologies, practice growth opportunities,  and upcoming elective trends in eye care.

Mark Kontos, MD, Empire Eye (RxSight, Inc.)

Marc Odrich, CMO, Lenz Therapeutics

Paul Smith, President & COO, Orasis Pharmaceuticals

PRO/CON DEBATE

Join us, as top industry physicians debate the hottest topics in eye care! 

ICL/Refractive

Patient Profile: What technology would you use?

Premium IOL’s/Dry Eye Protocols

PRESENTATION

The Modern Ophthalmology Practice

AI is already changing our everyday lives. This session will feature a series of presentations by leading experts focusing on advancing AI, what it means to our industry, and its impact on surgical practices and patients.

Peter Menzisuo, Company Group Chairman, Johnson & Johnson Vision (Moderator)

PANEL

The Great Debate: Glaucoma Drug Delivery Vs Drainage Devices

Leading industry and surgeon glaucoma experts will present some of the leading innovations in glaucoma. Join us to discuss recent technology advancements and the changing reimbursement environment.

Shawn O’Neil, Chief Commercial Officer, ViaLase Inc.

Mitchell Shultz, MD, Medical Director, Shultz Chang Vision, Co-Founder and Chief Medical Officer, Alchemy Vision

Kuldev Singh, MD, MPH, Professor of Ophthalmology and Director of the Glaucoma Service, Stanford University

EXPERIENCE

Closing Comments

Bill Carpou, CEO, Octane

Closing Reception

EXPERIENCE

Tier 1 Advisory Board Meetings

6:45 – 8:15 am

8:30 – 10:00 am (sold out)

10:15 – 11:45 am